Skip to main content
Explore URMC

menu

Multiple Myeloma

Research Question:
Is there a way to determine which patients are more or less likely to experience disease progression?

Basic Study Information

Purpose:
The purpose of this study is to collect clinical data along with bone marrow aspirate samples to see if there is a way to determine which patients are more or less likely to experience disease progression. This study will involve identifying different markers on the surfaces of the plasma cells and will look at protein expression. We will then correlate those findings with data from your medical records over time. If you decide to take part in this study, you will be asked to allow additional bone marrow aspirate and blood samples to be collected for research at several time points. These additional samples will be collected during routine testing time points as required for your routine care. We will also collect information about your disease and treatment from your medical record.

Location: cancer center
Study Reference #: ULAB-16115

Lead Researcher (Principal Investigator)

Lead Researcher: Brea Lipe

Study Contact Information

Study Coordinator: Erin Enfield
Phone: (585) 276-5790
Email: Erin_Enfield@urmc.rochester.edu

Additional Study Details

Return to Search